ascendis pharma glp-1 receptor agonists weight management diabetes treatments agonist medications GLP-1 receptor in the treatment of type 2 – state-of-the-art GLP-1 single, dual, and triple
Description
42 We filled the knowledge gap by providing direct head-to-head comparison results adjusted for lab-measured glucose level and kidney function in US adult patients with a broader age range
Given MSAs rapid progression, careful patient selection and well-powered trial design will be essential to detect potential disease-modifying effects
Innovent Biologics, Inc
Cereb Cortex
